Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2014, Article ID 723868, 6 pages
http://dx.doi.org/10.1155/2014/723868
Research Article

IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens

1Departments of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan
2Department of Molecular Virology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan
3Department of Gastroenterology, Kikkoman General Hospital, Noda 278-0005, Japan

Received 17 July 2014; Accepted 24 November 2014; Published 8 December 2014

Academic Editor: Shigeru Marubashi

Copyright © 2014 Tatsuo Miyamura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Tatsuo Kanda, Shingo Nakamoto, and Osamu Yokosuka, “Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C?,” World journal of virology, vol. 4, no. 3, pp. 178–84, 2015. View at Publisher · View at Google Scholar
  • Qin Wu, Cong Wang, En Qiang Chen, Hong Tang, Zhen Zhen Li, and Xue Zhong Lei, “Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-Analysis,” Hepatitis Monthly, vol. 15, no. 12, 2015. View at Publisher · View at Google Scholar
  • Itaru Ozeki, Tomoaki Nakajima, Masakatsu Yamaguchi, Mutsuumi Kimura, Tomohiro Arakawa, Yasuaki Kuwata, Takumi Ohmura, Takahiro Sato, Yoshihumi Iwaguti, Hiroko Gotoda, Shuhei Hige, Yoshiyasu Karino, and Joji Toyota, “A case of hepatocellular carcinoma after achieving sustained virologic response treated with asunaprevir/daclatasvir in chronic hepatitis C virus infection,” Kanzo, vol. 56, no. 7, pp. 348–355, 2015. View at Publisher · View at Google Scholar
  • Karina Gonzalez-Aldaco, Joao R. Rebello Pinho, Sonia Roman, Ketti Gleyzer, Nora A. Fierro, Leticia Oyakawa, Omar Ramos-Lopez, Rubia A. Ferraz Santana, Roberta Sitnik, and Arturo Panduro, “Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico,” Plos One, vol. 11, no. 1, 2016. View at Publisher · View at Google Scholar
  • Masato Nakamura, Shin Yasui, Yuki Haga, Sadahisa Ogasawara, Akinobu Tawada, Makoto Arai, Shigeru Mikami, Fumio Imazeki, Osamu Yokosuka, Tatsuo Kanda, Shingo Nakamoto, and Reina Sasaki, “Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Tr,” International Journal Of Medical Sciences, vol. 13, no. 4, pp. 310–315, 2016. View at Publisher · View at Google Scholar
  • Peng Huang, Yinan Yao, Ming Yue, Ting Tian, Hongbo Chen, Mingzhu Chen, Jie Wang, Yun Zhang, and Rongbin Yu, “Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population,” Scientific Reports, vol. 7, pp. 42408, 2017. View at Publisher · View at Google Scholar
  • Mohammad Pouryasin, Heidar Sharafi, Bita Behnava, Seyed Moayed Alavian, Maryam Keshvari, and Ali Pouryasin, “ A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients with Chronic Hepatitis C ,” Laboratory Medicine, pp. lmw060, 2017. View at Publisher · View at Google Scholar
  • Reina Sasaki, Keith Meyer, Mitsuhiko Moriyama, Naoya Kato, Osamu Yokosuka, Ratna B. Ray, Rajeev Aurora, Ranjit Ray, and Tatsuo Kanda, “Rapid hepatitis C virus clearance by antivirals correlates with immune status of infected patients,” Journal of Medical Virology, 2018. View at Publisher · View at Google Scholar